Werewolf Therapeutics, Inc.
Total Trades
41
Buys
2
Sells
39
Largest Trade
$1M+
Insiders
4
Institutional Funds
37
Inst. Value
$1M+
Activist Filings
27
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| EVNIN LUKE | Director | SELL | $15K–$50K | 39K | $0.54 | Jan 20, 2026 |
| EVNIN LUKE | Director | SELL | $50K–$100K | 111K | $0.56 | Jan 15, 2026 |
| EVNIN LUKE | Director | SELL | $50K–$100K | 91K | $0.59 | Jan 12, 2026 |
| EVNIN LUKE | Director | SELL | $15K–$50K | 71K | $0.65 | Jan 7, 2026 |
| EVNIN LUKE | Director | SELL | $15K–$50K | 78K | $0.62 | Jan 2, 2026 |
| EVNIN LUKE | Director | SELL | $100K–$500K | 291K | $0.64 | Dec 29, 2025 |
| EVNIN LUKE | Director | SELL | $50K–$100K | 48K | $1.08 | Dec 17, 2025 |
| EVNIN LUKE | Director | SELL | $50K–$100K | 83K | $1.07 | Dec 12, 2025 |
| EVNIN LUKE | Director | SELL | $50K–$100K | 95K | $1.00 | Dec 9, 2025 |
| EVNIN LUKE | Director | SELL | $100K–$500K | 128K | $0.92 | Dec 4, 2025 |
| MPM BioVentures 2014, L.P. | Insider | SELL | $100K–$500K | 200K | $0.92 | Dec 4, 2025 |
| GADICKE ANSBERT | Insider | SELL | $100K–$500K | 200K | $0.92 | Dec 4, 2025 |
| EVNIN LUKE | Director | SELL | $50K–$100K | 91K | $0.96 | Dec 1, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $100K–$500K | 142K | $0.96 | Dec 1, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $100K–$500K | 142K | $0.96 | Dec 1, 2025 |
| EVNIN LUKE | Director | SELL | $100K–$500K | 126K | $0.92 | Nov 25, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $100K–$500K | 196K | $0.92 | Nov 25, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $100K–$500K | 196K | $0.92 | Nov 25, 2025 |
| EVNIN LUKE | Director | SELL | $50K–$100K | 103K | $0.92 | Nov 20, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $100K–$500K | 160K | $0.92 | Nov 20, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $100K–$500K | 160K | $0.92 | Nov 20, 2025 |
| EVNIN LUKE | Director | SELL | $100K–$500K | 135K | $0.96 | Nov 18, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $100K–$500K | 210K | $0.96 | Nov 18, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $100K–$500K | 210K | $0.96 | Nov 18, 2025 |
| EVNIN LUKE | Director | SELL | $100K–$500K | 137K | $1.13 | Nov 13, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $100K–$500K | 214K | $1.13 | Nov 13, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $100K–$500K | 214K | $1.13 | Nov 13, 2025 |
| EVNIN LUKE | Director | SELL | $100K–$500K | 156K | $1.22 | Nov 7, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $100K–$500K | 243K | $1.22 | Nov 7, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $100K–$500K | 243K | $1.22 | Nov 7, 2025 |
| EVNIN LUKE | Director | SELL | $100K–$500K | 189K | $1.33 | Nov 4, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $100K–$500K | 295K | $1.33 | Nov 4, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $100K–$500K | 295K | $1.33 | Nov 4, 2025 |
| EVNIN LUKE | Director | SELL | $100K–$500K | 177K | $1.62 | Oct 29, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $100K–$500K | 276K | $1.62 | Oct 29, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $100K–$500K | 276K | $1.62 | Oct 29, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $100K–$500K | 536K | $0.91 | May 14, 2025 |
| MPM BioVentures 2014, L.P. | 10% Owner | SELL | $1K–$15K | 2K | $1.05 | Apr 30, 2025 |
| EVNIN LUKE | Director | SELL | $1K–$15K | 2K | $1.05 | Apr 30, 2025 |
| GADICKE ANSBERT | 10% Owner | SELL | $1K–$15K | 4K | $1.05 | Apr 30, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 1.9M | $2.21 | Jan 10, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 37 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DC Funds, LP | 589K | $1M+ | SH |
| RA CAPITAL MANAGEMENT, L.P. | 6.7M | $1M+ | SH |
| MPM BioImpact LLC | 1.4M | $500K+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 678K | $100K–$500K | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 627K | $100K–$500K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 279K | $100K–$500K | SH |
| Alyeska Investment Group, L.P. | 236K | $100K–$500K | SH |
| VANGUARD GROUP INC | 180K | $100K–$500K | SH |
| STATE STREET CORP | 119K | $50K–$100K | SH |
| JANE STREET GROUP, LLC | 98K | $50K–$100K | SH |
| Vontobel Holding Ltd. | 60K | $15K–$50K | SH |
| EDGEWOOD MANAGEMENT LLC | 50K | $15K–$50K | SH |
| GOLDMAN SACHS GROUP INC | 34K | $15K–$50K | SH |
| SIMPLEX TRADING, LLC | 24K | $15K–$50K | SH |
| UBS Group AG | 20K | $1K–$15K | SH |
| CERTUITY, LLC | 15K | $1K–$15K | SH |
| Delta Investment Management, LLC | 15K | $1K–$15K | SH |
| Point72 Asset Management, L.P. | 14K | $1K–$15K | SH |
| BARCLAYS PLC | 13K | $1K–$15K | SH |
| Larson Financial Group LLC | 13K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 11, 2026
3.5%
1.7M shares
SC 13D/A · Jan 16, 2026
3.0%
1.5M shares
SC 13D/A · Dec 29, 2025
3.6%
1.7M shares
SC 13D/A · Dec 4, 2025
4.3%
2.1M shares
SC 13D/A · Nov 18, 2025
4.9%
2.4M shares
SC 13D/A · Nov 6, 2025
13.8%
6.7M shares
SC 13D/A · Nov 4, 2025
5.8%
2.7M shares
SC 13G/A · Aug 14, 2025
0.9%
401K shares
SC 13D/A · May 14, 2025
15.0%
6.7M shares
SC 13G/A · Feb 14, 2025
6.5%
2.9M shares
SC 13G/A · Nov 14, 2024
7.8%
6 shares
BANK OF AMERICA CORP /DE/ 56-0906609
SC 13G/A · Nov 14, 2024
4.9%
2.2M shares
SC 13G/A · Nov 13, 2024
3.0%
1.3M shares
Adage Capital Management, L.P.
SC 13G/A · Nov 12, 2024
4.6%
2.0M shares
SC 13D/A · May 7, 2024
14.2%
6.2M shares
SC 13D/A · Feb 14, 2024
15.2%
6.2M shares
SC 13G/A · Feb 14, 2024
9.6%
6 shares
BANK OF AMERICA CORPORATION 56-0906609
SC 13G · Feb 13, 2024
5.8%
2.1M shares
SC 13G/A · Feb 12, 2024
5.3%
1.9M shares
SC 13G · Dec 21, 2023
8.4%
3.0M shares
SC 13G · Feb 10, 2023
6.0%
1.8M shares
SC 13G · Jan 17, 2023
5.3%
6 shares
SC 13G/A · Jan 17, 2023
4.2%
6 shares
SC 13D/A · Jan 10, 2023
18.0%
6.2M shares
SC 13D/A · Aug 12, 2022
14.6%
4.3M shares
SC 13G · May 2, 2022
5.5%
6 shares
SC 13G/A · Feb 11, 2022
3.5%
958K shares